Boldenone Undecylenate oil is a steroidal raw material also known as Equipoise, EQ, Boldenone 10-Undecenoate, and Boldenone Undec-10-Enoate. AAS Raw Pharma supplies yellowish oily Boldenone Undecylenate raw material with a stated assay of 99% for qualified laboratory research, analytical work, method development, reference testing, and legally authorised professional manufacturing.
The material is identified by CAS 13103-34-9, molecular formula C30H44O3, and molecular weight 452.67 g/mol. Its oily physical form distinguishes it from many crystalline steroid raw materials, but appearance alone cannot verify identity, purity, concentration, sterility, or suitability for a particular application.
AAS Raw Pharma supports qualified sample, development, and bulk enquiries subject to customer verification, product availability, destination regulations, and documented end use. Customers may request information about the current batch, available quality documents, packaging options, and commercial terms before ordering.
Important notice: This listing is for a bulk chemical raw material. It is not a finished Equipoise medicine, sterile injectable solution, dietary supplement, or consumer product, and it is not intended for direct human or veterinary administration. Boldenone Undecylenate is controlled or otherwise regulated in many jurisdictions. Buyers are responsible for confirming that purchase, possession, importation, transportation, storage, processing, and intended use are lawful.
Boldenone Undecylenate oil is the undecylenate ester of boldenone, a synthetic steroidal compound. The undecylenate component is also described as 10-undecenoate, which explains the recognised synonym Boldenone 10-Undecenoate.
The name Equipoise is historically associated with a finished veterinary drug containing Boldenone Undecylenate. However, the AAS Raw Pharma product described on this page is a bulk raw material rather than a finished branded veterinary preparation.
The FDA substance database identifies Equipoise as a brand name associated with Boldenone Undecylenate and records the molecular formula as C30H44O3 and the molecular weight as 452.67.
This distinction between the active raw material and a finished product is important. A raw oily substance has not necessarily undergone the formulation, sterility, stability, container-closure, concentration, and finished-product release testing required for an injectable veterinary medicine.
| Specification | Product details |
|---|---|
| Product name | Boldenone Undecylenate Oil |
| Alternative spelling | Boldenone Undecylenate |
| Common name | Equipoise |
| Common abbreviation | EQ |
| Recognised synonym | Boldenone 10-Undecenoate |
| Additional synonym | Boldenone Undec-10-Enoate |
| Chemical description | 17-beta-hydroxyandrosta-1,4-dien-3-one 10-undecenoate |
| CAS number | 13103-34-9 |
| EINECS number | 236-024-5 |
| UNII | ZS6D2ITA30 |
| Molecular formula | C30H44O3 |
| Molecular weight | 452.67 g/mol |
| Stated assay | 99%, subject to batch documentation |
| Appearance | Yellowish oily liquid |
| Physical form | Oil-like raw material |
| Listed grade | Pharmaceutical raw-material grade |
| Packaging | Sealed compatible container with protective secondary packaging |
| Documentation | Batch-specific documents available on request, where applicable |
| Intended users | Qualified laboratories, research institutions, and authorised manufacturers |
| Direct administration | Not permitted; this is not a finished medicinal product |
The molecular-weight field in the original supplied content incorrectly repeated the molecular formula. The verified molecular weight is approximately 452.67 g/mol. PubChem, the FDA substance record, and the NCI database independently report consistent identity information.
Product specifications on a general web page should be treated as commercial reference information. Final acceptance must be based on the actual batch label, agreed purchase specification, available Certificate of Analysis, and the customer’s own quality procedures.
Boldenone Undecylenate consists of boldenone esterified with undecylenic acid. The esterified compound has a distinct chemical identity from boldenone base, Boldenone Acetate, and other related steroidal substances.
The FDA’s validated substance record lists:
These identifiers should appear consistently in quotations, purchase orders, quality records, package labels, and receiving documentation. Using the full chemical name and CAS number reduces the possibility of confusion with other boldenone esters or finished Equipoise products.
Boldenone Undecylenate may appear in chemical databases and commercial catalogues under several names:
PubChem recognises Boldenone Undecylenate, Equipoise, Vebonol, and Boldenone 10-Undecenoate as associated names.
The supplied alias “Boldenone undecanoate” should be used cautiously. Undecanoate and undecylenate do not describe exactly the same ester structure. For this product, the correct procurement identity is Boldenone Undecylenate, CAS 13103-34-9.
The AAS Raw Pharma product specification describes the material as a yellowish oily liquid. Some raw-material catalogues similarly describe Boldenone Undecylenate as yellow oil or an oil-like substance.
Colour and viscosity may be influenced by temperature, storage history, container type, purity, and batch characteristics. A visual inspection can therefore form only one part of incoming-material evaluation.
Appearance cannot establish:
A raw oily material should not be described as an injectable preparation merely because its physical form resembles an oil. Appropriate testing and manufacturing controls are required before any regulated application.
The phrase Boldenone Undecylenate oil can refer to the neat ester’s naturally oily or viscous physical form. It can also be used imprecisely by some suppliers to describe a formulated solution containing a carrier oil.
These are not necessarily the same product.
| Product form | Description |
|---|---|
| Neat raw material | Boldenone Undecylenate in its bulk oil-like form |
| Analytical solution | A known concentration dissolved in a stated laboratory solvent |
| Carrier-oil preparation | A formulated mixture containing the active ingredient and one or more excipients |
| Finished veterinary product | A regulated dosage form manufactured and released under applicable requirements |
AAS Raw Pharma should clearly state on the final listing whether the 99% product is neat raw material or a formulated solution. If it is a mixture, the carrier, concentration, and full composition should be disclosed. A product containing a carrier oil must not be advertised as 99% neat Boldenone Undecylenate unless analytical and compositional records support that claim.
The AAS Raw Pharma specification lists a stated assay of 99%. This value should be connected to the particular batch and the analytical method used rather than treated as a universal characteristic of every product sold under the same name.
A meaningful assay statement depends on:
Customers requiring a minimum assay should request the current batch’s Certificate of Analysis before placing an order. Independent incoming testing may also be appropriate, depending on the customer’s quality system and intended lawful application.
Raw-material quality should be assessed with more than a headline purity percentage. Depending on the agreed specification, quality evaluation may include:
The applicable tests and limits must be confirmed from the actual AAS Raw Pharma specification and batch records. The website should not claim HPLC, GC-MS, NMR, heavy-metal, residual-solvent, sterility, endotoxin, or microbiological testing unless those tests were performed and documented for the supplied batch.
A recognised reference-material supplier lists Boldenone Undecylenate as an analytical reference standard with a purity specification of at least 98%, while emphasising that batch-specific results are supplied on the corresponding COA. That information illustrates good documentation practice but does not substantiate the AAS Raw Pharma batch.
A Certificate of Analysis, or COA, is a batch-specific document summarising tests performed and results obtained. Depending on the AAS Raw Pharma specification, a COA may include:
Customers should confirm that the lot number printed on the container matches the lot number on the COA. A generic sample document or another supplier’s COA must not be represented as evidence for the batch offered by AAS Raw Pharma.
Where customer procedures require independent verification, the material should remain appropriately quarantined until sampling, testing, review, and release have been completed.
A Safety Data Sheet may contain information about hazards, handling, storage, accidental release, exposure response, disposal, and transportation. Trained personnel should review the applicable SDS before opening, sampling, transferring, or processing the product.
Cayman Chemical’s product information warns that Boldenone Undecylenate should be considered hazardous until more information is available and advises against ingestion, inhalation, skin contact, and eye contact. Its reference material is intended for research and forensic applications rather than human or veterinary diagnostic or therapeutic use.
Customers should request the current AAS Raw Pharma SDS where available. Another supplier’s SDS may provide useful background but cannot replace documentation for the exact product and formulation being purchased.
The supplied product information describes this material as pharmaceutical grade. That expression should be used only when AAS Raw Pharma can support it with a defined specification and appropriate documentation.
“Pharmaceutical grade” does not automatically establish that a material is:
If the product meets only an internal or enterprise specification, describe it precisely as meeting the applicable in-house standard. Avoid adding regulatory logos or certifications unless AAS Raw Pharma holds current, verifiable authorisation to use them.
Equipoise is historically associated with a veterinary injectable product containing Boldenone Undecylenate. In the United States, federal regulations describe a veterinary dosage form containing Boldenone Undecylenate for specified use in horses and state that it is restricted to use by or on the order of a licensed veterinarian. The regulation also says it must not be administered to horses intended for human consumption.
That regulatory context applies to an authorised finished veterinary dosage form. It does not mean that bulk Boldenone Undecylenate oil may be administered directly or used to create an unlicensed veterinary product.
AAS Raw Pharma supplies raw material, not veterinary treatment. The website should avoid describing the product as a ready-to-use horse medicine or making treatment claims based on the history of the Equipoise brand.
A bulk active material and a finished veterinary medicine are fundamentally different products.
| Characteristic | Bulk Boldenone Undecylenate oil | Finished veterinary product |
|---|---|---|
| Product type | Raw chemical material | Regulated dosage form |
| Concentration | Not necessarily expressed in mg/mL | Defined and labelled |
| Excipients | None or separately disclosed | Controlled formulation |
| Sterility | Not implied | Required when applicable |
| Container closure | Bulk packaging | Qualified finished-product packaging |
| Release testing | Raw-material specification | Finished-product specification |
| Administration | Not permitted directly | Only as lawfully authorised |
| Label claims | Chemical and commercial data | Regulator-approved information |
A 99% assay does not establish sterility, freedom from endotoxins, concentration, injectable suitability, clinical safety, or regulatory approval.
Subject to applicable laws and customer qualification, Boldenone Undecylenate raw material may be relevant to:
The product’s availability does not authorise any specific use. Each customer is responsible for confirming that its organisation, facility, personnel, licences, and intended application satisfy applicable legal and regulatory requirements.
Boldenone Undecylenate and boldenone base are related but chemically distinct substances.
| Feature | Boldenone Undecylenate | Boldenone base |
|---|---|---|
| Chemical form | Undecylenate ester | Unesterified parent compound |
| CAS number | 13103-34-9 | 846-48-0 |
| Molecular formula | C30H44O3 | C19H26O2 |
| Molecular weight | 452.67 g/mol | Approximately 286.41 g/mol |
| Common association | Equipoise | Boldenone |
| Interchangeable | No | No |
The FDA maintains separate substance identities for Boldenone Undecylenate and boldenone.
Purchasers should specify the complete product name and CAS number to avoid receiving the wrong substance.
The terms undecylenate and undecanoate are sometimes used interchangeably on supplier websites, but chemically they are not identical.
Undecylenate refers to an unsaturated ester containing a carbon-carbon double bond. Undecanoate refers to the corresponding saturated ester. The product associated with Equipoise and CAS 13103-34-9 is Boldenone Undecylenate, also described as Boldenone 10-Undecenoate.
For accuracy, AAS Raw Pharma should use:
The alias “Boldenone undecanoate” should be removed from the primary product specification unless documentation establishes that a separate undecanoate product is being offered.
Storage conditions should come from product-specific stability information, the batch label, COA, or SDS. Cayman Chemical specifies -20 degrees C for its analytical solution, but that condition applies to its particular acetonitrile formulation and should not automatically be assigned to neat AAS Raw Pharma raw oil.
General storage practices include:
Do not publish a shelf life or exact storage temperature without supporting stability or batch documentation.
Boldenone Undecylenate is biologically active and potentially regulated. It should be handled only by trained personnel operating under an appropriate risk assessment.
Professional controls may include:
The material must not be swallowed, inhaled deliberately, injected, applied to the body, or administered to an animal. It must be kept away from children and unauthorised individuals.
Because this material is oily rather than a free-flowing crystalline powder, packaging should be selected for liquid compatibility, seal integrity, containment, and transport durability.
Possible packaging may include:
Every package should carry clear product, batch, quantity, and handling information. Packaging options depend on the quantity, destination, transport requirements, and applicable regulations.
AAS Raw Pharma does not offer disguised, falsely declared, or deliberately mislabeled packaging. Customs declarations and shipping documents must accurately describe the goods.
Samples may be available to qualified laboratories, institutions, and authorised businesses, subject to inventory, customer verification, destination law, and stated end use.
For a sample or bulk quotation, customers should provide:
Availability, minimum order quantity, price, production capacity, and lead time should be confirmed in a formal quotation. Avoid publishing “free samples” or guaranteed monthly capacity unless those terms are current and consistently available.
AAS Raw Pharma supports qualified customers seeking documented steroidal raw materials for lawful professional applications.
The listed assay for this Boldenone Undecylenate oil is 99%, subject to the analytical documentation associated with the supplied batch.
The product is identified by its correct chemical name, CAS number, molecular formula, molecular weight, and recognised synonyms.
Direct sourcing can support competitive quotations for approved development and bulk requirements. Final pricing depends on quantity, testing, packaging, stock, destination, and documentation.
Customers may request the available COA, SDS, product specification, and other technical information for the current batch.
Packaging can be selected according to the oily physical form, required quantity, containment needs, and lawful transport conditions.
AAS Raw Pharma can review logistics options where exportation, transport, importation, possession, and intended use are legal.
Customers can request support concerning order records, batch documentation, packaging, and shipment information. Any discrepancy should be reported promptly with the order and batch details.
To request a quotation for Boldenone Undecylenate raw oil, provide complete commercial and compliance information:
AAS Raw Pharma may request additional information before accepting an order. An enquiry does not guarantee availability, customs clearance, or approval.
International delivery may be assessed where the shipment is lawful and accepted by an appropriate carrier. Potential carriers can include DHL, FedEx, UPS, TNT, EMS, or a specialist freight provider, depending on route, quantity, classification, and packaging.
The purchaser is responsible for confirming:
AAS Raw Pharma does not guarantee customs clearance and does not support deceptive labels, false values, concealed contents, or inaccurate customs declarations.
Boldenone Undecylenate is regulated differently across jurisdictions. In the United States, federal regulations address a specified veterinary finished product for horses and restrict it to use by or on the order of a licensed veterinarian.
Other jurisdictions may classify the substance as a controlled anabolic steroid, veterinary pharmaceutical ingredient, prescription-related substance, research chemical, or prohibited sports substance.
Depending on destination and intended use, a purchaser may need:
The buyer should obtain independent legal or regulatory advice where necessary. Publication of this product page does not establish that the substance may be acquired or used in a particular location.
This page provides technical and commercial information about a raw chemical material. It does not recommend Boldenone Undecylenate for bodybuilding, muscle gain, hormone replacement, athletic performance, veterinary self-treatment, or any other personal application.
The original dosage, injection-frequency, injection-site, stacking, and cycle instructions have intentionally been excluded. Those instructions are inappropriate for a bulk raw material and could facilitate unsafe or unlawful administration.
AAS Raw Pharma does not claim that this raw material diagnoses, treats, cures, or prevents a disease. Any lawful veterinary treatment must be directed by a licensed veterinarian and use an appropriately authorised finished product.
Boldenone Undecylenate oil is the oil-like raw form of the undecylenate ester of boldenone. It is identified by CAS 13103-34-9 and is intended for qualified research, analytical, and legally authorised professional applications.
Boldenone Undecylenate is the active substance historically associated with the veterinary brand name Equipoise. Raw material is not the same as a finished Equipoise veterinary product.
EQ is a common abbreviation used for Equipoise or Boldenone Undecylenate. Formal purchasing documents should use the full chemical name and CAS number.
The CAS number is 13103-34-9.
The molecular formula is C30H44O3.
The molecular weight is approximately 452.67 g/mol.
The AAS Raw Pharma specification describes it as a yellowish oily liquid rather than a conventional free-flowing powder. The title and product attributes should therefore refer to oil or raw material rather than raw powder.
The stated assay is 99%, subject to verification in the documentation for the relevant batch.
Available batch documents may be requested before purchase. Customers should confirm exactly which COA, SDS, specification, and analytical records accompany the order.
The final listing should explicitly state whether the product is neat raw material or a formulated solution. If diluted, the solvent or carrier and concentration should be disclosed.
Sterility must not be assumed. Unless an exact batch has been produced, tested, and released to a documented sterile specification, treat it as non-sterile raw material.
No. It is not a sterile, formulated, regulated, or ready-to-administer injectable preparation.
No. Raw material must not be administered directly. Veterinary treatment requires a licensed veterinarian and a legally authorised finished product.
No. Dosage, injection, stacking, and steroid-cycle instructions are inappropriate for a bulk chemical ingredient.
No. Undecylenate is an unsaturated ester, while undecanoate is saturated. The Equipoise-associated compound on this page is Boldenone Undecylenate, CAS 13103-34-9.
No. Boldenone Undecylenate and boldenone base have different CAS numbers, molecular formulas, and molecular weights.
A sample may be available to qualified customers, depending on inventory, intended use, destination restrictions, verification, and commercial terms.
Bulk enquiries may be assessed according to stock, production capacity, customer qualification, documentation, quantity, and destination law.
Possible formats include sealed compatible bottles, leak-resistant inner containers, protective secondary packaging, or approved bulk containers.
Keep it tightly sealed, protected from light, and secured against unauthorised access. Follow the exact temperature and storage conditions stated on the AAS Raw Pharma batch label and technical documentation.
International delivery may be possible where exportation, transport, importation, possession, and intended use are lawful.
No. The buyer is responsible for permits, declarations, duties, taxes, and destination-country requirements.
Provide the required quantity, destination, organisation details, intended lawful use, packaging preference, specification, and required documentation.
| Specification | Product details |
|---|---|
| Product name | Boldenone Undecylenate Oil |
| Alternative spelling | Boldenone Undecylenate |
| Common name | Equipoise |
| Common abbreviation | EQ |
| Recognised synonym | Boldenone 10-Undecenoate |
| Additional synonym | Boldenone Undec-10-Enoate |
| Chemical description | 17-beta-hydroxyandrosta-1,4-dien-3-one 10-undecenoate |
| CAS number | 13103-34-9 |
| EINECS number | 236-024-5 |
| UNII | ZS6D2ITA30 |
| Molecular formula | C30H44O3 |
| Molecular weight | 452.67 g/mol |
| Stated assay | 99%, subject to batch documentation |
| Appearance | Yellowish oily liquid |
| Physical form | Oil-like raw material |
| Listed grade | Pharmaceutical raw-material grade |
| Packaging | Sealed compatible container with protective secondary packaging |
| Documentation | Batch-specific documents available on request, where applicable |
| Intended users | Qualified laboratories, research institutions, and authorised manufacturers |
| Direct administration | Not permitted; this is not a finished medicinal product |
